Is Neurocrine Biosciences, Inc. technically bullish or bearish?

As of 3 October 2025, the technical trend for Neurocrine Biosciences, Inc. has changed from bullish to mildly bullish. The weekly and monthly MACD indicators are bullish, while the daily moving averages also indicate a bullish stance. However, the KST shows a mildly bearish signal on both weekly and monthly time frames, and the Dow Theory reflects a mildly bullish trend on a monthly basis. The Bollinger Bands are bullish weekly and mildly bullish monthly, while the OBV is bullish monthly with no trend weekly.
In terms of performance, Neurocrine has underperformed the S&P 500 over the past week and month, with returns of -0.60% and -3.24% compared to 1.09% and 4.15% for the index, respectively. However, it has outperformed the S&P 500 over the past year with a return of 22.31% versus 17.82%. Overall, the current technical stance is mildly bullish, driven by the bullish MACD and moving averages, despite some mixed signals from KST and Dow Theory.